Annual ROE
-72.09%
+3.00%+4.00%
30 June 2024
Summary:
InMed Pharmaceuticals annual return on equity is currently -72.09%, with the most recent change of +3.00% (+4.00%) on 30 June 2024. During the last 3 years, it has risen by +81.86% (+53.17%). INM annual ROE is now -110.86% below its all-time high of 663.53%, reached on 30 June 2008.INM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-66.76%
+3.34%+4.76%
30 September 2024
Summary:
InMed Pharmaceuticals quarterly return on equity is currently -66.76%, with the most recent change of +3.34% (+4.76%) on 30 September 2024. Over the past year, it has dropped by -8.05% (-13.71%). INM quarterly ROE is now -102.05% below its all-time high of 3252.96%, reached on 30 September 2004.INM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INM ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.0% | -13.7% |
| 3 y3 years | +53.2% | +48.0% |
| 5 y5 years | -23.2% | +1.7% |
INM ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +68.1% | -28.6% | +59.3% |
| 5 y | 5 years | -23.2% | +68.1% | -28.6% | +59.3% |
| alltime | all time | -110.9% | +99.8% | -102.0% | +96.0% |
InMed Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -66.76%(-4.8%) |
| June 2024 | -72.09%(-4.0%) | -70.10%(+33.7%) |
| Mar 2024 | - | -52.44%(+1.0%) |
| Dec 2023 | - | -51.92%(-11.6%) |
| Sept 2023 | - | -58.71%(-13.0%) |
| June 2023 | -75.09%(-66.8%) | -67.47%(-49.7%) |
| Mar 2023 | - | -134.15%(-5.9%) |
| Dec 2022 | - | -142.55%(-10.1%) |
| Sept 2022 | - | -158.53%(-3.3%) |
| June 2022 | -226.07%(+46.8%) | -163.93%(+36.1%) |
| Mar 2022 | - | -120.45%(-3.1%) |
| Dec 2021 | - | -124.29%(-3.2%) |
| Sept 2021 | - | -128.34%(-10.1%) |
| June 2021 | -153.95%(+70.2%) | -142.68%(+17.2%) |
| Mar 2021 | - | -121.69%(+10.6%) |
| Dec 2020 | - | -110.02%(+7.4%) |
| Sept 2020 | - | -102.45%(+8.0%) |
| June 2020 | -90.47%(+54.6%) | -94.84%(+2.0%) |
| Mar 2020 | - | -92.97%(+12.7%) |
| Dec 2019 | - | -82.48%(+21.5%) |
| Sept 2019 | - | -67.91%(+18.5%) |
| June 2019 | -58.52%(+20.8%) | -57.33%(+9.5%) |
| Mar 2019 | - | -52.35%(+5.8%) |
| Dec 2018 | - | -49.49%(-6.0%) |
| Sept 2018 | - | -52.67%(-11.0%) |
| June 2018 | -48.44%(-51.1%) | -59.15%(-23.0%) |
| Mar 2018 | - | -76.78%(-15.6%) |
| Dec 2017 | - | -90.99%(-30.1%) |
| Sept 2017 | - | -130.12%(-5.5%) |
| June 2017 | -99.05%(-43.5%) | -137.67%(-19.3%) |
| Mar 2017 | - | -170.57%(-10.1%) |
| Dec 2016 | - | -189.79%(-5.2%) |
| Sept 2016 | - | -200.26%(-3.8%) |
| June 2016 | -175.33%(-29.1%) | -208.27%(-30.5%) |
| Mar 2016 | - | -299.72%(-20.9%) |
| Dec 2015 | - | -379.10%(+13.8%) |
| Sept 2015 | - | -333.11%(+9.3%) |
| June 2015 | -247.42%(+58.5%) | -304.87%(-20.4%) |
| Mar 2015 | - | -382.85%(+19.8%) |
| Dec 2014 | - | -319.51%(-9.1%) |
| Sept 2014 | - | -351.49%(-29.8%) |
| June 2014 | -156.15%(-247.5%) | -501.05%(-385.9%) |
| Mar 2014 | - | 175.28%(+20.6%) |
| Dec 2013 | - | 145.28%(+38.9%) |
| Sept 2013 | - | 104.58%(-45.0%) |
| June 2013 | 105.90% | 190.15%(-116.1%) |
| Mar 2013 | - | -1177.44%(+238.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | -348.38%(+47.5%) |
| Sept 2012 | - | -236.12%(+46.7%) |
| June 2012 | -185.27%(+15.1%) | -160.96%(+156.8%) |
| Mar 2012 | - | -62.69%(-63.7%) |
| Dec 2011 | - | -172.73%(-201.7%) |
| Sept 2011 | - | 169.83%(+176.8%) |
| June 2011 | -160.90%(-648.0%) | 61.36%(+38.5%) |
| Mar 2011 | - | 44.29%(+114.3%) |
| Dec 2010 | - | 20.67%(-15.7%) |
| Sept 2010 | - | 24.51%(-8.4%) |
| June 2010 | 29.36%(-71.5%) | 26.75%(+93.0%) |
| Mar 2010 | - | 13.86%(-2.7%) |
| Dec 2009 | - | 14.25%(-52.8%) |
| Sept 2009 | - | 30.17%(-73.2%) |
| June 2009 | 102.99%(-84.5%) | 112.58%(-37.4%) |
| Mar 2009 | - | 179.74%(-34.5%) |
| Dec 2008 | - | 274.36%(-38.7%) |
| Sept 2008 | - | 447.49%(+35.3%) |
| June 2008 | 663.53%(+236.5%) | 330.85%(+3.5%) |
| Mar 2008 | - | 319.70%(+13.3%) |
| Dec 2007 | - | 282.20%(+6.2%) |
| Sept 2007 | - | 265.75%(-20.4%) |
| June 2007 | 197.20%(-24.8%) | 333.79%(+19.0%) |
| Mar 2007 | - | 280.50%(-16.1%) |
| Dec 2006 | - | 334.24%(-4.1%) |
| Sept 2006 | - | 348.45%(+26.8%) |
| June 2006 | 262.15%(-36.7%) | 274.70%(-42.0%) |
| Mar 2006 | - | 473.70%(-32.2%) |
| Dec 2005 | - | 698.46%(-11.0%) |
| Sept 2005 | - | 785.10%(-39.7%) |
| June 2005 | 414.36%(-100.9%) | 1301.16%(-36.3%) |
| Mar 2005 | - | 2044.11%(+27.9%) |
| Dec 2004 | - | 1597.72%(-50.9%) |
| Sept 2004 | - | 3252.96%(-293.1%) |
| July 2004 | -48.22 K%(>+9900.0%) | -1684.50%(+249.2%) |
| Apr 2004 | - | -482.35%(+46.3%) |
| Jan 2004 | - | -329.63%(+57.3%) |
| Oct 2003 | - | -209.56%(+38.1%) |
| July 2003 | -160.79%(+62.1%) | -151.72%(+27.9%) |
| Apr 2003 | - | -118.60%(+0.2%) |
| Jan 2003 | - | -118.31%(+5.6%) |
| Oct 2002 | - | -112.03%(-6.0%) |
| July 2002 | -99.20%(-2.9%) | -119.19%(+43.6%) |
| Apr 2002 | - | -82.98%(+64.3%) |
| Jan 2002 | - | -50.51%(+122.8%) |
| Oct 2001 | - | -22.67% |
| July 2001 | -102.14% | - |
FAQ
- What is InMed Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual ROE year-on-year change?
- What is InMed Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly ROE year-on-year change?
What is InMed Pharmaceuticals annual return on equity?
The current annual ROE of INM is -72.09%
What is the all time high annual ROE for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual return on equity is 663.53%
What is InMed Pharmaceuticals annual ROE year-on-year change?
Over the past year, INM annual return on equity has changed by +3.00% (+4.00%)
What is InMed Pharmaceuticals quarterly return on equity?
The current quarterly ROE of INM is -66.76%
What is the all time high quarterly ROE for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly return on equity is 3252.96%
What is InMed Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, INM quarterly return on equity has changed by -8.05% (-13.71%)